STUDY OF DNA FRAGMENTATION AND APOPTOSIS-RELATED GENE PRODUCTS IN HUMAN BRAIN TUMORS AND ESTABLISHMENT OF APOPTOSIS-INDUCING THERAPY.

人脑肿瘤中DNA片段和凋亡相关基因产物的研究及凋亡诱导疗法的建立。

基本信息

  • 批准号:
    07457319
  • 负责人:
  • 金额:
    $ 4.35万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

1. We detected the internucleosomal DNA fragmentation by modified TUNEL staining and analyzed the expression of apoptosis-related gene products in cultured glioma cells and biopsied brain tumor specimens. The fragmented and condensed nuclei were clearly stained for TUNEL and the percentages of stained nuclei (apoptotic index) were ranging from 0% to 8.9%. Fas, Bcl-2 families (Bcl-2, Bcl-x and Bax) and ICE families (ICE,Ich-1) were found to be involved in tumorigenesis of certain brain tumors.2. We investigated the role of the Fas ligand-Fas system in human glioblastoma cell lines (T98G,U251 and A172).Immunohistochemical and flow cytometrical analyzes revealed that all three cell lines expressed Fas highly, however, apoptotic changes such as nuclear fragmentation, the DNA ladder pattern on gel electrophoresis, and reduction of viable cells were observed only in T98G cells by treatment of Fas mAb (50ng/ml).3. We have been applying an adoptive immunotherapy protocol to patients with malignant brain tumors using OK-432-activated peripheral blood mononuclear cells (OK-MCs). To elucidate the mechanism of OK-MCs' cytotoxicity, we examined the cytocidal activity of OK-MCs against Fas expressing T98G glioma cells.Apoptosis of T98G cells induced by treatment with OK-MCs was unequivocally inhibited by the treatment of T98G cells with ZB4 monoclonal antibody, which binds to Fas and blocks the binding of Fas ligand to Fas. These results indicate that the cytotoxic activity of OK-MCs via apoptosis seems to be partly mediated by the Fas ligand/Fas system.
1.采用改良TUNEL法检测神经胶质瘤细胞核小体DNA片段化,并分析胶质瘤细胞凋亡相关基因产物的表达。断裂和凝聚的细胞核被TUNEL清楚地染色,染色细胞核的百分比(凋亡指数)范围为0%至8.9%。Fas、Bcl-2家族(Bcl-2、Bcl-x和Bax)和ICE家族(ICE、Ich-1)参与了某些脑肿瘤的发生.我们研究了Fas配体-Fas系统在人胶质母细胞瘤细胞系中的作用,免疫组化和流式细胞术分析显示,三种细胞系均高表达Fas,但均出现凋亡改变,如核碎裂、凝胶电泳DNA梯状条带、Fas单抗(50 ng/ml)处理T98 G细胞后,仅T98 G细胞活细胞数减少.我们一直在应用过继免疫治疗方案,恶性脑肿瘤患者使用OK-432激活的外周血单核细胞(OK-MCs)。为了阐明OK-MCs的细胞毒作用机制,我们检测了OK-MCs对表达Fas的T98 G胶质瘤细胞的杀伤活性,结果表明,与Fas结合并阻断Fas配体与Fas结合的ZB 4单克隆抗体能明显抑制OK-MCs诱导的T98 G细胞凋亡。这些结果表明,OK-MCs通过凋亡的细胞毒活性似乎部分由Fas配体/Fas系统介导。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Setsuko Nakagawa: "Detection of DNA strand breaks associated with apoptosis in human brain tumors" Virchows Arch. 427. 175-179 (1995)
Setsuko Nakakawa:“检测与人脑肿瘤细胞凋亡相关的 DNA 链断裂”Virchows Arch。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
白石哲也: "アポトーシスの分子機構と神経疾患" 脳神経外科. 23. 563-574 (1995)
Tetsuya Shiraishi:“细胞凋亡和神经疾病的分子机制”《神经外科》23. 563-574 (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
田渕和雄: "脳腫瘍におけるアポトーシス関連遺伝子の発現とアポトーシス誘導療法" 日本臨床. 54. 1922-1928 (1996)
Kazuo Tabuchi:“脑肿瘤中凋亡相关基因的表达和凋亡诱导疗法”日本临床研究 54。1922-1928(1996)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
白石哲也: "グリオーマにおけるFas-Fasリガンド系の役割とアポトーシス" Cytometry Research. 5. 83-88 (1995)
Tetsuya Shiraishi:“Fas-Fas 配体系统和神经胶质瘤细胞凋亡的作用”细胞计数研究。5. 83-88 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kazuo Tabuchi, et al.: "Expression of apoptosis-related gene products in human brain tumors and apoptosis-inducing therapy" Nihon Rynsho. 54. 1922-1928 (1996)
Kazuo Tabuchi 等人:“人脑肿瘤中凋亡相关基因产物的表达和凋亡诱导疗法”Nihon Rynsho。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TABUCHI Kazuo其他文献

TABUCHI Kazuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TABUCHI Kazuo', 18)}}的其他基金

Development of new strategies for cancer treatment based in system biological-analysis of cancer system abnormality
基于癌症系统异常的系统生物学分析开发癌症治疗新策略
  • 批准号:
    15390439
  • 财政年份:
    2003
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biomarker Discovery of CSF biomarker of medulloblastoma by SELDI-TOF mass spectrometry
生物标志物 通过 SELDI-TOF 质谱法发现髓母细胞瘤的 CSF 生物标志物
  • 批准号:
    12470293
  • 财政年份:
    2000
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of apoptosis-related products in delayed neuronal death following cerebral ischemia
脑缺血后迟发性神经元死亡的凋亡相关产物分析
  • 批准号:
    10557129
  • 财政年份:
    1998
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular diagnosis of glioblastomas based on genetic alterations.
基于遗传改变的胶质母细胞瘤的分子诊断。
  • 批准号:
    09470298
  • 财政年份:
    1997
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
STUDY ON THE DIAGNOSIS AND THERAPY OF BRAIN TUMORS IN TERMS OF GENETIC ENGINEERING
脑肿瘤的基因工程诊断和治疗研究
  • 批准号:
    04454363
  • 财政年份:
    1992
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Study on Oncogenes and Growth-Related Antigens of Human Brain Tumors
人脑肿瘤癌基因及生长相关抗原的研究
  • 批准号:
    01480551
  • 财政年份:
    1989
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Qualitative and quantitative study of oncogene-products in gliomas.
神经胶质瘤中癌基因产物的定性和定量研究。
  • 批准号:
    60570673
  • 财政年份:
    1985
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Mathematical Models for Carcinogenesis Based on the Evidence of Molecular Biology and Its Application to Data Analysis
基于分子生物学证据的致癌数学模型及其在数据分析中的应用
  • 批准号:
    14380123
  • 财政年份:
    2002
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
脊髄慢性圧迫による前角細胞の遺伝子発現とアポトーシス
慢性脊髓压迫导致前角细胞的基因表达和凋亡
  • 批准号:
    11770769
  • 财政年份:
    1999
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Encouragement of Young Scientists (A)
Molecular mechanism of paclitaxel on CDDP resistant ovarian cancer
紫杉醇治疗CDDP耐药卵巢癌的分子机制
  • 批准号:
    10671523
  • 财政年份:
    1998
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinicopathological study in the relationship among sensitivity, clonality, and growth potential after treatment in human gliomas
人胶质瘤敏感性、克隆性和治疗后生长潜力之间关系的临床病理学研究
  • 批准号:
    09671407
  • 财政年份:
    1997
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Apoptsis in mammalian morphogenesis.
哺乳动物形态发生中的细胞凋亡。
  • 批准号:
    06454140
  • 财政年份:
    1994
  • 资助金额:
    $ 4.35万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了